Compare Novartis with INDUCON(I) - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs INDO EURO CHEM - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS INDO EURO CHEM NOVARTIS/
INDO EURO CHEM
 
P/E (TTM) x 82.4 269.2 30.6% View Chart
P/BV x 2.6 1.0 253.7% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 NOVARTIS   INDO EURO CHEM
EQUITY SHARE DATA
    NOVARTIS
Mar-21
INDO EURO CHEM
Mar-20
NOVARTIS/
INDO EURO CHEM
5-Yr Chart
Click to enlarge
High Rs77012 6,353.1%   
Low Rs50110 5,273.7%   
Sales per share (Unadj.) Rs154.57.0 2,206.2%  
Earnings per share (Unadj.) Rs8.50 24,712.2%  
Cash flow per share (Unadj.) Rs13.40.1 13,030.1%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs289.210.6 2,724.7%  
Shares outstanding (eoy) m24.699.05 272.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.11.5 266.3%   
Avg P/E ratio x75.1310.7 24.2%  
P/CF ratio (eoy) x47.5105.0 45.2%  
Price / Book Value ratio x2.21.0 215.7%  
Dividend payout %118.10-   
Avg Mkt Cap Rs m15,69198 16,030.9%   
No. of employees `000NANA-   
Total wages/salary Rs m1,0851 120,566.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,81463 6,018.8%  
Other income Rs m3323 10,091.2%   
Total revenues Rs m4,14667 6,219.8%   
Gross profit Rs m267-2 -12,467.3%  
Depreciation Rs m1221 19,612.9%   
Interest Rs m770 85,333.3%   
Profit before tax Rs m4000 91,000.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1910 147,230.8%   
Profit after tax Rs m2090 67,419.4%  
Gross profit margin %7.0-3.4 -206.8%  
Effective tax rate %47.828.6 167.3%   
Net profit margin %5.50.5 1,105.9%  
BALANCE SHEET DATA
Current assets Rs m9,22483 11,068.6%   
Current liabilities Rs m3,57363 5,713.4%   
Net working cap to sales %148.232.8 451.5%  
Current ratio x2.61.3 193.7%  
Inventory Days Days176414 42.5%  
Debtors Days Days37236 15.7%  
Net fixed assets Rs m2,48077 3,233.5%   
Share capital Rs m12390 136.6%   
"Free" reserves Rs m7,0186 122,692.3%   
Net worth Rs m7,14196 7,433.5%   
Long term debt Rs m01 0.0%   
Total assets Rs m11,703160 7,313.6%  
Interest coverage x6.25.9 105.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.30.4 82.3%   
Return on assets %2.40.3 974.0%  
Return on equity %2.90.3 895.4%  
Return on capital %6.70.5 1,230.8%  
Exports to sales %9.30-   
Imports to sales %00-   
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3540-   
Fx outflow Rs m9740-   
Net fx Rs m-6210-   
CASH FLOW
From Operations Rs m-6926 -12,036.5%  
From Investments Rs m952-2 -59,105.6%  
From Financial Activity Rs m-368-4 9,919.1%  
Net Cashflow Rs m-1090 -25,833.3%  

Share Holding

Indian Promoters % 0.0 55.9 -  
Foreign collaborators % 73.4 0.0 -  
Indian inst/Mut Fund % 1.3 0.6 227.1%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.6 44.1 60.3%  
Shareholders   44,652 5,211 856.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   AASHEE INFOTECH  SICAGEN INDIA  MUNOTH INVESTMENTS  TOHEAL PHARMA  RUTRON INTER.  



Today's Market

Sensex, Nifty Continue Downtrend to End Lower for 4th Day; Metal & IT Stocks Drag(Closing)

After opening the day on a positive note, Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

Modi's Big Move Could Boost these 5 Defence Stocks(Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

5 Green Energy Stocks to Watch as India Readies for a Revolution(Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

Could HDFC Bank be a Big EV Winner? The Answer Will Surprise You...(Profit Hunter)

Oct 13, 2021

Why should investors take it for granted that India's Tesla will be one of the major auto stocks?

Massive Surge in the Shares of Tata Motors Today. Key Factors Favouring the Rally(Views On News)

Oct 13, 2021

Tata Motors zooms 23% after report of TPG investing Rs 75 bn in EV arm.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Oct 22, 2021 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS